Singular Genomics | ARS:年度报告
Singular Genomics | DEF 14A:股东委托书决议
Singular Genomics | DEFA14A:其他
Singular Genomics | PRE 14A:并购重组委托声明
Singular Genomics | 4:持股变动声明-高管 Ropp Sam
Singular Genomics | 4:持股变动声明-高管 Meeter Dalen
Singular Genomics | 4:持股变动声明-高管 Glezer Eli N.
Singular Genomics | 4:持股变动声明-高管 Spaventa Andrew
Singular Genomics | S-8:员工福利计划证券登记
Singular Genomics | 10-K:年度报表
Singular Genomics | 8-K:Singular Genomics报告了近期亮点以及2023年第四季度和全年财务业绩
Singular Genomics | SC 13G/A:超过5%持股股东披露文件(修正)-Eli Glezer(6.6%)
Singular Genomics | SC 13G/A:超过5%持股股东披露文件(修正)-Andrew Spaventa(7.9%)
Singular Genomics | 4:持股变动声明-高管 Ropp Sam
Singular Genomics | 4:持股变动声明-高管 Ghai Jyotsna
Singular Genomics | 4:持股变动声明-高管 Meeter Dalen
Singular Genomics | 4:持股变动声明-高管 Glezer Eli N.
Singular Genomics | 4:持股变动声明-高管 Spaventa Andrew
Singular Genomics | SC 13G/A:超过5%持股股东披露文件(修正)-Deerfield Management Company, L.P.(6.83%),James E. Flynn(6.83%)等
Singular Genomics | SC 13G/A:超过5%持股股东披露文件(修正)-Domain Partners IX, L.P.(5.1%),Domain Associates, LLC(Less than 0.1%)
暂无数据